Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the antitumor activity, toxicity, and effectiveness of the combination of
goserelin (Zoladex) and anastrozole (Arimidex) in the treatment of premenopausal women with
hormone receptor positive metastatic carcinoma of the breast.